Clinical Trial Update: Pembrolizumab and Lenvatinib in Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of pembrolizumab and lenvatinib in advanced cervical cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Georgetown University | Conditions: Cervical Cancer, Metastatic Cervical Cancer | Phase 2 | Status: RECRUITING